Inozyme Pharma Starts Dosing In INZ-701 Trial For Calcification Disorders
Inozyme Pharma Inc (NASDAQ:INZY) has dosed the first patient in its Phase 1/2 trial of INZ-701 in adult patients with ABCC6…
YouTube Trader Matt Kohrs Discussing Support.com, Says ‘Hopefully [Support.com Shares] Just Putting In A Lower High
https://www.youtube.com/watch?v=bsmp4KOYtZ4
Related Posts
Jazz Obtains Exclusive Rights To Zymeworks’ Cancer Candidate In Almost $2B Biobuck Deal
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) will acquire development and commercialization rights to Zymeworks Inc’s (NASDAQ:ZYME) zanidatamab across all indications in the U.S., Europe, Japan,…
Karyopharm Shares Fall After Selinexor Data In Endometrial Cancer Patients
Karyopharm Therapeutics Inc's (NASDAQ: KPTI) Phase 3 SIENDO selinexor study has
Kadena, NEM Among Top Crypto Movers In 24H
According to Benzinga Pro, the following are the crypto gainers and losers at the time of publication: